Registration of securities issued in business combination transactions

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY

v3.20.4
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY - USD ($)
Total
IPO
Private Placement
Ordinary Shares
Ordinary Shares
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Private Placement
Retained earnings (Accumulated Deficit)
Balance at beginning of period at Nov. 05, 2018 $ 0     $ 0   $ 0     $ 0
Balance at beginning of period (in shares) at Nov. 05, 2018       0          
Increase (Decrease) in Stockholders' Equity                  
Issuance of ordinary shares to Sponsor [1] 25,000     $ 719   24,281      
Issuance of ordinary shares to Sponsor (in shares) [1]       7,187,500          
Net income (loss) (2,694)               (2,694)
Balance at end of period at Dec. 31, 2018 22,306     $ 719   24,281     (2,694)
Balance at end of period (in shares) at Dec. 31, 2018       7,187,500          
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) (13,739)               (13,739)
Balance at end of period at Mar. 31, 2019 8,567     $ 719   24,281     (16,433)
Balance at end of period (in shares) at Mar. 31, 2019       7,187,500          
Balance at beginning of period at Dec. 31, 2018 22,306     $ 719   24,281     (2,694)
Balance at beginning of period (in shares) at Dec. 31, 2018       7,187,500          
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 3,076,468                
Balance at end of period at Sep. 30, 2019 5,000,005     $ 811   1,925,420     3,073,774
Balance at end of period (in shares) at Sep. 30, 2019       8,110,156          
Balance at beginning of period at Dec. 31, 2018 22,306     $ 719   24,281     (2,694)
Balance at beginning of period (in shares) at Dec. 31, 2018       7,187,500          
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offerings, gross   $ 287,500,000 $ 7,750,000   $ 2,875   $ 287,497,125 $ 7,750,000  
Sale of units in initial public offering, gross (in shares)       28,750,000 28,750,000        
Offering costs (15,075,329)         (15,075,329)      
Ordinary shares subject to possible redemption (279,423,730)     $ (2,794)   (279,420,936)      
Ordinary shares subject to possible redemption (in shares)       (27,942,373)          
Net income (loss) 4,226,759               4,226,759
Balance at end of period at Dec. 31, 2019 5,000,006     $ 800   775,141     4,224,065
Balance at end of period (in shares) at Dec. 31, 2019       7,995,127          
Balance at beginning of period at Mar. 31, 2019 8,567     $ 719   24,281     (16,433)
Balance at beginning of period (in shares) at Mar. 31, 2019       7,187,500          
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offerings, gross   $ 287,500,000 $ 7,750,000   $ 2,875   $ 287,497,125 $ 7,750,000  
Sale of units in initial public offering, gross (in shares)         28,750,000        
Offering costs (15,075,329)         (15,075,329)      
Common stock subject to possible redemption (276,823,340)     $ (2,768)   (276,820,572)      
Common stock subject to possible redemption (in shares)       (27,682,334)          
Net income (loss) 1,640,103               1,640,103
Balance at end of period at Jun. 30, 2019 5,000,001     $ 826   3,375,505     1,623,670
Balance at end of period (in shares) at Jun. 30, 2019       8,255,166          
Increase (Decrease) in Stockholders' Equity                  
Ordinary shares subject to possible redemption (1,450,100)     $ (15)   (1,450,085)      
Ordinary shares subject to possible redemption (in shares)       (145,010)          
Net income (loss) 1,450,104               1,450,104
Balance at end of period at Sep. 30, 2019 5,000,005     $ 811   1,925,420     3,073,774
Balance at end of period (in shares) at Sep. 30, 2019       8,110,156          
Balance at beginning of period at Dec. 31, 2019 5,000,006     $ 800   775,141     4,224,065
Balance at beginning of period (in shares) at Dec. 31, 2019       7,995,127          
Increase (Decrease) in Stockholders' Equity                  
Ordinary shares subject to possible redemption (961,620)     $ (10)   (775,141)     (186,469)
Ordinary shares subject to possible redemption (in shares)       (96,162)          
Net income (loss) 961,618               961,618
Balance at end of period at Mar. 31, 2020 5,000,004     $ 790         4,999,214
Balance at end of period (in shares) at Mar. 31, 2020       7,898,965          
Balance at beginning of period at Dec. 31, 2019 5,000,006     $ 800   775,141     4,224,065
Balance at beginning of period (in shares) at Dec. 31, 2019       7,995,127          
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offering, gross (in shares)       28,750,000          
Net income (loss) (120,091)                
Balance at end of period at Sep. 30, 2020 5,000,005     $ 801   895,230     4,103,974
Balance at end of period (in shares) at Sep. 30, 2020       8,007,136          
Balance at beginning of period at Mar. 31, 2020 5,000,004     $ 790         4,999,214
Balance at beginning of period (in shares) at Mar. 31, 2020       7,898,965          
Increase (Decrease) in Stockholders' Equity                  
Ordinary shares subject to possible redemption 110,220     $ 1         110,219
Ordinary shares subject to possible redemption (in shares)       11,022          
Net income (loss) (110,220)               (110,220)
Balance at end of period at Jun. 30, 2020 5,000,004     $ 791         4,999,213
Balance at end of period (in shares) at Jun. 30, 2020       7,909,987          
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offering, gross (in shares)       28,750,000          
Ordinary shares subject to possible redemption 971,490     $ 10   895,230     76,250
Ordinary shares subject to possible redemption (in shares)       97,149          
Net income (loss) (971,489)               (971,489)
Balance at end of period at Sep. 30, 2020 $ 5,000,005     $ 801   $ 895,230     $ 4,103,974
Balance at end of period (in shares) at Sep. 30, 2020       8,007,136          
[1] This number includes up to 937,500 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On April 5, 2019, the underwriters fully exercised their over-allotment option; thus, the 937,500 Founder Shares were no longer subject to forfeiture.